{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:47:30Z","timestamp":1791305250118,"version":"4.3.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["26343, 28054, 29829"],"award-info":[{"award-number":["26343, 28054, 29829"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["26343, 28054, 29829"],"award-info":[{"award-number":["26343, 28054, 29829"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2020-1 12978"],"award-info":[{"award-number":["2020-1 12978"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2020-1 12978"],"award-info":[{"award-number":["2020-1 12978"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020349","name":"Fondazione Italiana per la ricerca sulle Malattie del Pancreas","doi-asserted-by":"publisher","award":["J38D19000690001"],"award-info":[{"award-number":["J38D19000690001"]}],"id":[{"id":"10.13039\/100020349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020349","name":"Fondazione Italiana per la ricerca sulle Malattie del Pancreas","doi-asserted-by":"publisher","award":["J38D19000690001"],"award-info":[{"award-number":["J38D19000690001"]}],"id":[{"id":"10.13039\/100020349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["(RF CO-2019-12369662: CUP: B39C21000370001"],"award-info":[{"award-number":["(RF CO-2019-12369662: CUP: B39C21000370001"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glucagonomas are functioning pancreatic neuroendocrine tumors (PanNETs) responsible for glucagonoma syndrome. This study aims to shed light on the clinicopathological and molecular features of these neoplasms. Six patients with glucagonomas were identified. All neoplasms were investigated with immunohistochemistry for neuroendocrine markers (Synaptophysin, Chromogranin-A), ATRX, DAXX, ARX, and PDX1 transcription factors. Fluorescent in situ hybridization (FISH) for assessing alternative lengthening of telomeres (ALT), and next-generation sequencing (NGS) for molecular profiling were performed. All cases were large single masses (mean size of 8.2\u00a0cm), with necrolytic migratory erythema as the most common symptom (6\/6 cases, 100%). All neoplasms were well-differentiated G1 tumors, except one case that was G2. The tumors consistently showed classic\/conventional histomorphology, with solid-trabecular and nested architecture. Lymphatic and vascular invasion (6\/6, 100%), perineural infiltration (4\/6, 66.6%), and nodal metastasis (4\/6, 66.6%) were frequently observed. Transcription factors expression showed strong ARX expression in all tumors, and PDX1 expression in 5\/6 cases (83.3%), indicating co-occurring alpha- and beta-cell differentiation. NGS showed recurrent somatic <jats:italic>MEN1<\/jats:italic> and <jats:italic>ATRX\/DAXX<\/jats:italic> biallelic inactivation. Cases with <jats:italic>ATRX<\/jats:italic> or <jats:italic>DAXX<\/jats:italic> mutations also showed matched loss of ATRX or DAXX protein expression and ALT. One case harbored somatic <jats:italic>MUTYH<\/jats:italic> inactivation and showed a high tumor mutational burden (TMB, 41.0 mut\/Mb). During follow-up, one patient died of the disease, and four patients developed distant metastasis. Pancreatic glucagonomas are distinct PanNETs with specific clinicopathological and molecular features, including histological aspects of biological aggressiveness, co-occurring alpha- and beta-cell differentiation, <jats:italic>MEN1<\/jats:italic> and <jats:italic>DAXX<\/jats:italic>\/<jats:italic>ATRX<\/jats:italic> mutations enrichment, and the possible presence of high-TMB as an actionable marker.<\/jats:p>","DOI":"10.1007\/s12022-024-09826-z","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T13:02:59Z","timestamp":1727442179000},"page":"354-361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX\/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)"],"prefix":"10.1007","volume":"35","author":[{"given":"Paola","family":"Mattiolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bevere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mafficini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Vera D.","family":"Verschuur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Calicchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel M.","family":"Hackeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Simbolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Paiella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen M. A.","family":"Dreijerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Pedron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cingarlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Salvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Milella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita T.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlof D.","family":"Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R.","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk A.","family":"Brosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"1","key":"9826_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL (2022). Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol 33(1):115-154. https:\/\/doi.org\/10.1007\/s12022-022-09708-2","journal-title":"Endocr Pathol"},{"issue":"2","key":"9826_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17446651.2024.2320639","volume":"19","author":"S Massironi","year":"2024","unstructured":"Massironi S (2024). The diagnostic challenges of functioning neuroendocrine tumors: balancing accuracy, availability, and personalized care. Expert Rev Endocrinol Metab 19(2):99-101. https:\/\/doi.org\/10.1080\/17446651.2024.2320639","journal-title":"Expert Rev Endocrinol Metab"},{"key":"9826_CR3","doi-asserted-by":"publisher","unstructured":"Bevere M, Gkountakos A, Martelli FM, Scarpa A, Luchini C, Simbolo M (2023). An insight on functioning pancreatic neuroendocrine neoplasms. Biomedicines 2023 21;11(2):303. https:\/\/doi.org\/10.3390\/biomedicines11020303","DOI":"10.3390\/biomedicines11020303"},{"key":"9826_CR4","doi-asserted-by":"publisher","unstructured":"Hofland J, Falconi M, Christ E, Casta\u00f1o JP, Faggiano A, Lamarca A, Perren A, Petrucci S, Prasad Vikas, Rusznieski P, Thirlwell C, Vullierme M, Welin S, Bartsch D (2023). European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol 35(8):e13318. https:\/\/doi.org\/:https:\/\/doi.org\/10.1111\/jne.13318","DOI":"10.1111\/jne.13318"},{"key":"9826_CR5","doi-asserted-by":"publisher","unstructured":"Alvarez M, Almanzar A, Sanabria F, Meneses G, Velasquez L, Zarate L (2020). Manifestations of glucagonoma syndrome. AACE Clin Case Rep 3;6(1):e46-e49. https:\/\/doi.org\/10.4158\/ACCR-2019-0211","DOI":"10.4158\/ACCR-2019-0211"},{"key":"9826_CR6","doi-asserted-by":"publisher","unstructured":"Perrier M, Brugel M, G\u00e9rard L, Goichot B, Li\u00e8vre A, Lepage C, Hautefeuille V, Do Cao C, Smith D, Thuillier P, Cros J, Cadiot G, Walter T, de Mestier L (2023). Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network. Eur J Endocrinol 6;189(6):575\u2013583. https:\/\/doi.org\/10.1093\/ejendo\/lvad157","DOI":"10.1093\/ejendo\/lvad157"},{"key":"9826_CR7","doi-asserted-by":"publisher","unstructured":"Hackeng WM, Brosens LAA, Dreijerink KMA (2023). Aggressive versus indolent insulinomas: new clinicopathological insights. Endocr Relat Cancer 27;30(5):e220321. https:\/\/doi.org\/10.1530\/ERC-22-0321","DOI":"10.1530\/ERC-22-0321"},{"issue":"2","key":"9826_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12022-020-09611-8","volume":"31","author":"WM Hackeng","year":"2020","unstructured":"Hackeng WM, Schelhaas W, Morsink FHM, Heidsma CM, van Eeden S, Valk GD, Vriens MR, Heaphy CM, Nieveen van Dijkum EJM, Offerhaus GJA, et al (2020). Alternative lengthening of telomeres and differential expression of endocrine transcription factors distinguish metastatic and non-metastatic insulinomas. Endocr Pathol 31(2):108-118. https:\/\/doi.org\/10.1007\/s12022-020-09611-8","journal-title":"Endocr Pathol"},{"issue":"1","key":"9826_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00428-018-2437-7","volume":"474","author":"RT Lawlor","year":"2019","unstructured":"Lawlor RT, Dapr\u00e0 V, Girolami I, Pea A, Pilati C, Nottegar A, Piccoli P, Parolini C, Sperandio N, Capelli P, Scarpa A, Luchini C (2019). CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas. Virchows Arch 474(1):105-109. https:\/\/doi.org\/10.1007\/s00428-018-2437-7","journal-title":"Virchows Arch"},{"issue":"3","key":"9826_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/PAI.0000000000000175","volume":"24","author":"C Luchini","year":"2016","unstructured":"Luchini C, Parcesepe P, Nottegar A, Parolini C, Mafficini A, Remo A, Chilosi M, Manfrin E (2016). CD71 in gestational pathology: a versatile immunohistochemical marker with new possible applications. Appl Immunohistochem Mol Morphol 24(3):215-20. https:\/\/doi.org\/10.1097\/PAI.0000000000000175","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"5","key":"9826_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/gutjnl-2020-322595","volume":"71","author":"WM Hackeng","year":"2022","unstructured":"Hackeng WM, Brosens LAA, Kim JY, O'Sullivan R, Sung YN, Liu TC, Cao D, Heayn M, Brosnan-Cashman J, An S, et al (2022). Non-functional pancreatic neuroendocrine tumours: ATRX\/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX\/PDX1 expression and tumour size. Gut 71(5):961-973. https:\/\/doi.org\/10.1136\/gutjnl-2020-322595","journal-title":"Gut"},{"issue":"4","key":"9826_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/genes12040481","volume":"12","author":"A Mafficini","year":"2021","unstructured":"Mafficini A, Lawlor RT, Ghimenton C, Antonello D, Cant\u00f9 C, Paolino G, Nottegar A, Piredda ML, Salvia R, Milella M, Dei Tos AP, Fassan M, Scarpa A, Luchini C (2021). Solid pseudopapillary neoplasm of the pancreas and abdominal desmoid tumor in a patient carrying two different BRCA2 germline mutations: new horizons from tumor molecular profiling. Genes (Basel) 12(4):481. https:\/\/doi.org\/10.3390\/genes12040481","journal-title":"Genes (Basel)"},{"key":"9826_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.humpath.2021.09.006","volume":"118","author":"RT Lawlor","year":"2021","unstructured":"Lawlor RT, Mafficini A, Sciammarella C, Cant\u00f9 C, Rusev BC, Piredda ML, Antonello D, Grimaldi S, Bonizzato G, Sperandio N, et al (2021). Genomic characterization of hepatoid tumors: context matters. Hum Pathol 118:30-41. https:\/\/doi.org\/10.1016\/j.humpath.2021.09.006","journal-title":"Hum Pathol"},{"issue":"5","key":"9826_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405-24. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"9826_CR15","doi-asserted-by":"publisher","unstructured":"D\u00edaz-Gay M, Vila-Casades\u00fas M, Franch-Exp\u00f3sito S, Hern\u00e1ndez-Ill\u00e1n E, Lozano JJ, Castellv\u00ed-Bel S (2018). Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples. BMC Bioinformatics 14;19(1):224. https:\/\/doi.org\/10.1186\/s12859-018-2234-y","DOI":"10.1186\/s12859-018-2234-y"},{"issue":"7","key":"9826_CR16","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1210\/jc.2017-02646","volume":"103","author":"A Tamura","year":"2018","unstructured":"Tamura A, Ogasawara T, Fujii Y, Kaneko H, Nakayama A, Higuchi S, Hashimoto N, Miyabayashi Y, Fujimoto M, Komai E, et al (2018). Glucagonoma with necrolytic migratory erythema: metabolic profile and detection of biallelic inactivation of DAXX gene. J Clin Endocrinol Metab 103(7):2417-2423. https:\/\/doi.org\/10.1210\/jc.2017-02646","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9826_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1159\/000441605","volume":"103","author":"IE Luna","year":"2015","unstructured":"Luna IE, Monrad N, Binderup T, Boisen Thoegersen C, Hilsted L, Jensen C, Federspiel B, Knigge U (2015). Somatostatin-immunoreactive pancreaticoduodenal neuroendocrine neoplasms: twenty-three cases evaluated according to the WHO 2010 classification. Neuroendocrinology. 103(5):567-77. https:\/\/doi.org\/10.1159\/000441605","journal-title":"Neuroendocrinology."},{"issue":"1","key":"9826_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00428-010-0985-6","volume":"458","author":"B Konukiewitz","year":"2011","unstructured":"Konukiewitz B, Enosawa T, Kl\u00f6ppel G (2011). Glucagon expression in cystic pancreatic neuroendocrine neoplasms: an immunohistochemical analysis. Virchows Arch 458(1):47-53. https:\/\/doi.org\/10.1007\/s00428-010-0985-6","journal-title":"Virchows Arch"},{"issue":"3","key":"9826_CR19","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3892\/ol.2017.7703","volume":"15","author":"X Song","year":"2018","unstructured":"Song X, Zheng S, Yang G, Xiong G, Cao Z, Feng M, Zhang T, Zhao Y (2018). Glucagonoma and the glucagonoma syndrome. Oncol Lett 15(3):2749-2755. https:\/\/doi.org\/10.3892\/ol.2017.7703","journal-title":"Oncol Lett"},{"issue":"4","key":"9826_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","volume":"24","author":"\u00c5 Segerstolpe","year":"2016","unstructured":"Segerstolpe \u00c5, Palasantza A, Eliasson P, Andersson EM, Andr\u00e9asson AC, Sun X, Picelli S, Sabirsh A, Clausen M, Bjursell MK, et al (2016). Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab 24(4):593-607. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.020","journal-title":"Cell Metab"},{"issue":"4","key":"9826_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cels.2016.08.011","volume":"3","author":"M Baron","year":"2016","unstructured":"Baron M, Veres A, Wolock SL, Faust AL, Gaujoux R, Vetere A, Ryu JH, Wagner BK, Shen-Orr SS, Klein AM, Melton DA, Yanai I (2016). A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure. Cell Syst 3(4):346-360.e4. https:\/\/doi.org\/10.1016\/j.cels.2016.08.011","journal-title":"Cell Syst"},{"key":"9826_CR22","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00251","volume":"8","author":"CJ Paller","year":"2024","unstructured":"Paller CJ, Tukachinsky H, Maertens A, Decker B, Sampson JR, Cheadle JP, Antonarakis ES (2024). Pan-cancer interrogation of MUTYH variants reveals biallelic inactivation and defective base excision repair across a spectrum of solid tumors. JCO Precis Oncol 8:e2300251. https:\/\/doi.org\/10.1200\/PO.23.00251","journal-title":"JCO Precis Oncol"},{"issue":"17","key":"9826_CR23","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-21-0327","volume":"27","author":"L Marcus","year":"2021","unstructured":"Marcus L, Fashoyin-Aje LA, Donoghue M, Yuan M, Rodriguez L, Gallagher PS, Philip R, Ghosh S, Theoret MR, Beaver JA, Pazdur R, Lemery SJ (2021). FDA approval summary: pembrolizumab for the treatment of tumor mutational burden-high solid tumors. Clin Cancer Res 27(17):4685-4689. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-0327","journal-title":"Clin Cancer Res"},{"issue":"7643","key":"9826_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature24026","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, et al (2017). Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 543(7643):65-71. https:\/\/doi.org\/10.1038\/nature24026.","journal-title":"Nature"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09826-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-024-09826-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09826-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:08:36Z","timestamp":1734631716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-024-09826-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9826"],"URL":"https:\/\/doi.org\/10.1007\/s12022-024-09826-z","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"10 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}